Cited by 2,586Nanoparticle-Based Drug DeliveryNanotechnology research and applicationsAdvanced Drug Delivery Systems

The DOI matches its Crossref record; 91 of the 94 references it cites were found in a registry or an index.

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Bobo, Daniel, Robinson, Kye J., Islam, Jiaul, Thurecht, Kristofer J., Corrie, Simon R.·2016·Pharmaceutical Research

DOI 10.1007/s11095-016-1958-5

Open this paper in CoChat — free account

Abstract

In this review we provide an up to date snapshot of nanomedicines either currently approved by the US FDA, or in the FDA clinical trials process. We define nanomedicines as therapeutic or imaging agents which comprise a nanoparticle in order to control the biodistribution, enhance the efficacy, or otherwise reduce toxicity of a drug or biologic. We identified 51 FDA-approved nanomedicines that met this definition and 77 products in clinical trials, with ~40% of trials listed in clinicaltrials.gov started in 2014 or 2015. While FDA approved materials are heavily weighted to polymeric, liposomal, and nanocrystal formulations, there is a trend towards the development of more complex materials comprising micelles, protein-based NPs, and also the emergence of a variety of inorganic and metallic particles in clinical trials. We then provide an overview of the different material categories represented in our search, highlighting nanomedicines that have either been recently approved, or are already in clinical trials. We conclude with some comments on future perspectives for nanomedicines, which we expect to include more actively-targeted materials, multi-functional materials ("theranostics") and more complicated materials that blur the boundaries of traditional material categories. A key challenge for researchers, industry, and regulators is how to classify new materials and what additional testing (e.g. safety and toxicity) is required before products become available.

Integrity signals

Registry

Crossref · 10.1007/s11095-016-1958-5

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
Retracted
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,996
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
Chaudhuri, R. G., & Paria, S. (2011) · Chemical Reviews · doi:10.1021/cr100449n · Cited by 3,682
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El‐Sayed, M. A. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15237h · Cited by 3,659

Show all 94 references

Research works printed but not linked: 2

Duncan R, Sat YN. Tumour targeting by enhanced permeability and retention (EPR) effect. Ann Oncol. 1998;9:39. · DOI
Cures P. Neglected disease research and development: is the global financial crisis changing R&D. London: Policy Cures; 2011.

Sorted by citations

Items 301–400 of 1,006

Theranostic nanoparticles with disease-specific administration strategies
Zhang, P., Li, Y., Tang, W., Zhao, J., Jing, L., & McHugh, K. J. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101335 · Cited by 120
Nanomedicine to target multidrug resistant tumors
Lepeltier, É., Rijo, P. M., Rizzolio, F., Popovtzer, R., Petrikaitė, V., Assaraf, Y. G., & Passirani, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100704 · Cited by 116
Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications
Frtús, A., Smolková, B., Uzhytchak, M., Lunová, M., Jirsa, M., Kubinová, Š., Dejneka, A., & Lunov, O. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.036 · Cited by 119
Engineering polyphenol-based polymeric nanoparticles for drug delivery and bioimaging
Wang, X., Fan, Y., Yan, J., & Yang, M. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135661 · Cited by 120
Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy
Bostami, R. D. A., Abuwatfa, W. H., & Husseini, G. A. (2022) · Nanomaterials · doi:10.3390/nano12152672 · Cited by 128
Current status of nanomaterial-based treatment for hepatocellular carcinoma
Baig, B., Halim, S. S. A., Farrukh, A., Greish, Y. E., & Amin, A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108852 · Cited by 115
Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment
Wong, K. H., Lü, A., Chen, X., & Yang, Z. (2020) · Molecules · doi:10.3390/molecules25163620 · Cited by 122
Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma
Luo, L., Iqbal, M. Z., Chuang, L. I. U., Xing, J., Akakuru, O. U., Fang, Q., Li, Z., Dai, Y., Li, A., Guan, Y., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119464 · Cited by 114
Food additives containing nanoparticles induce gastrotoxicity, hepatotoxicity and alterations in animal behavior: The unknown role of oxidative stress
Medina‐Reyes, E. I., Rodríguez‐Ibarra, C., Déciga‐Alcaraz, A., Díaz‐Urbina, D., Chirino, Y. I., & Pedraza‐Chaverrí, J. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111814 · Cited by 116
Polymers and inorganic nanoparticles: A winning combination towards assembled nanostructures for cancer imaging and therapy
Yang, K., Zhang, S., He, J., & Nie, Z. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101046 · Cited by 116
Manganese-based advanced nanoparticles for biomedical applications: future opportunity and challenges
Haque, S., Tripathy, S., & Patra, C. R. (2021) · Nanoscale · doi:10.1039/d1nr04964j · Cited by 119
Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug
Mu, Y., Fu, Y., Li, J., Yu, X., Li, Y., Wang, Y., Wu, X., Zhang, K., Kong, M., Feng, C., et al. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.09.020 · Cited by 113
Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis
Razzak, R. A., Florence, G. J., & Gunn‐Moore, F. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123108 · Cited by 118
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Chen, Q., Sun, T., & Jiang, C. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00622-6 · Cited by 115
Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review
Ghazi, R., Ibrahim, T. K., Nasir, J. A., Gai, S., Ali, G., Boukhris, I., & Rehman, Z. (2025) · RSC Advances · doi:10.1039/d5ra00728c · Cited by 123
Tuning the In Vivo Transport of Anticancer Drugs Using Renal‐Clearable Gold Nanoparticles
Peng, C., Xu, J., Yu, M., Ning, X., Huang, Y., Du, B., Hernandez, E., Kapur, P., Hsieh, J., & Zheng, J. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903256 · Cited by 111
Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
Nag, O. K., & Delehanty, J. B. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100543 · Cited by 121
Toxicity and cellular uptake of lipid nanoparticles of different structure and composition
Strachan, J. B., Dyett, B., Nasa, Z., Valéry, C., & Conn, C. E. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.05.002 · Cited by 112
Nanotechnology advances towards development of targeted-treatment for obesity
Sibuyi, N. R. S., Moabelo, K. L., Meyer, M., Onani, M. O., Dube, A., & Madiehe, A. M. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0554-3 · Cited by 113
Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment
Carvalho, G. C., Sábio, R. M., Ribeiro, T. D. C., Monteiro, A. S., Pereira, D. V., Ribeiro, S. J. L., & Chorilli, M. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02917-6 · Cited by 111
Current outlook on radionuclide delivery systems: from design consideration to translation into clinics
Peltek, O. O., Muslimov, A. R., Zyuzin, M. V., & Timin, A. S. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0524-9 · Cited by 116
Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities
Carrion, C. C., Nasrollahzadeh, M., Sajjadi, M., Jaleh, B., Soufi, G. J., & Iravani, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.123 · Cited by 110
The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development
Ramos, T. I., Villacis-Aguirre, C. A., López-Aguilar, K. V., Padilla, L. S., Altamirano, C., Toledo, J. R., & Vispo, N. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020247 · Cited by 111
Liposome bilayer stability: emphasis on cholesterol and its alternatives
Nsairat, H., Ibrahim, A. A., Jaber, A. M., Abdelghany, S. M., Atwan, R., Shalan, N. M., Abdelnabi, H., Odeh, F., El‐Tanani, M., & Alshaer, W. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2226216 · Cited by 118
Nanomedicines: The magic bullets reaching their target?
Flühmann, B., Ntai, I., Borchard, G., Simoens, S., & Mühlebach, S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.11.019 · Cited by 108
An overview of polymeric nanomicelles in clinical trials and on the market
Zheng, X., Xie, J., Zhang, X., Sun, W., Zhao, H., Li, Y., & Wang, C. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.11.029 · Cited by 112
Polymeric nanocarriers: A promising tool for early diagnosis and efficient treatment of colorectal cancer
Haider, M. A., Zaki, K. Z., Hamshary, M. R. E., Hussain, Z., Orive, G., & Ibrahim, H. O. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.008 · Cited by 110
Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface
Serpooshan, V., Sheibani, S., Pushparaj, P., Wojcik, M., Jang, A. Y., Santoso, M. R., Jang, J. H., Huang, H., Safavi‐Sohi, R., Haghjoo, N., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b06212 · Cited by 108
Design, Synthesis and Architectures of Hybrid Nanomaterials for Therapy and Diagnosis Applications
Macchione, M. A., Biglione, C., & Strumia, M. C. (2018) · Polymers · doi:10.3390/polym10050527 · Cited by 116
On the Choice of the Extracellular Vesicles for Therapeutic Purposes
Campanella, C., Bavisotto, C. C., Logozzi, M., Marino, A., Mizzoni, D., Cappello, F., & Fais, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020236 · Cited by 108
The success of nanomedicine
Lammers, T., & Mauro Ferrari, B. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100853 · Cited by 111
Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia
de la Encarnación, C., de Aberasturi, D. J., & Liz‐Marzán, L. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114484 · Cited by 108
Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPR
Amin, M., Lammers, T., & ten Hagen, T. L. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114503 · Cited by 112
Bright insights into palladium-triggered local chemotherapy
Bray, T. L., Salji, M. J., Brombin, A., Pérez‐López, A. M., Rubio‐Ruíz, B., Galbraith, L. C. A., Patton, E. E., Leung, H. Y., & Unciti‐Broceta, A. (2018) · Chemical Science · doi:10.1039/c8sc02291g · Cited by 106
Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy
Janko, C., Ratschker, T., Nguyen, K., Zschiesche, L., Tietze, R., Lyer, S., & Alexiou, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00059 · Cited by 107
Nanoparticles for biomedical applications: exploring and exploiting molecular interactions at the nano-bio interface
Nienhaus, K., Wang, H., & Nienhaus, G. U. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2019.100036 · Cited by 107
Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging
DuPont, J. J., McCurley, A., Davel, A. P., McCarthy, J., Bender, S. B., Hong, K., Yang, Y., Yoo, J., Aronovitz, M. J., Baur, W. E., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88942 · Cited by 107
Forming next-generation antibody–nanoparticle conjugates through the oriented installation of non-engineered antibody fragments
Greene, M. K., Richards, D. A., Nogueira, J. C. F., Campbell, K., Smyth, P., Fernández, M., Scott, C. J., & Chudasama, V. (2017) · Chemical Science · doi:10.1039/c7sc02747h · Cited by 105
Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging
Chee, H. L., Gan, C. R. R., Ng, M., Low, L., Fernig, D. G., Bhakoo, K. K., & Paramelle, D. (2018) · ACS Nano · doi:10.1021/acsnano.7b07572 · Cited by 107
Self-Assembled Hybrid Nanostructures: Versatile Multifunctional Nanoplatforms for Cancer Diagnosis and Therapy
Li, M., Luo, Z. Y., & Zhao, Y. (2017) · Chemistry of Materials · doi:10.1021/acs.chemmater.7b03924 · Cited by 107
Design strategies for physical-stimuli-responsive programmable nanotherapeutics
Sahle, F. F., Gulfam, M., & Lowe, T. L. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.04.003 · Cited by 103
Urokinase-Conjugated Magnetite Nanoparticles as a Promising Drug Delivery System for Targeted Thrombolysis: Synthesis and Preclinical Evaluation
Prilepskii, A. Y., Fakhardo, A. F., Drozdov, A. S., Vinogradov, V. V., Dudanov, I. P., Shtil, A. A., Beltyukov, P. P., Shibeko, A. M., Михайловна, К. Е., Nechipurenko, D. Y., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14790 · Cited by 105
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Saeed, M., Chen, F., Ye, J., Shi, Y., Lammers, T., Geest, B. G. D., Xu, Z. P., & Yu, H. (2021) · Advanced Materials · doi:10.1002/adma.202008094 · Cited by 102
Polymeric particle-based therapies for acute inflammatory diseases
Brannon, E. R., Guevara, M. V., Pacifici, N. J., Lee, J. K., Lewis, J. S., & Eniola‐Adefeso, O. (2022) · Nature Reviews Materials · doi:10.1038/s41578-022-00458-5 · Cited by 103
Recent advances in waste-recycled nanomaterials for biomedical applications: Waste-to-wealth
Elkodous, M. A., El‐Husseiny, H. M., El-Sayyad, G. S., Hashem, A. H., Doghish, A. S., Elfadil, D., Radwan, Y., El-Zeiny, H. M., Bedair, H., Ikhdair, O. A., et al. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0099 · Cited by 106
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
Pijeira, M. S. O., Viltres, H., Kozempel, J., Sakmár, M., Vlk, M., İlem‐Özdemir, D., Ekinci, M., Srinivasan, S., Rajabzadeh, A. R., Ricci‐Júnior, E., et al. (2022) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-022-00161-4 · Cited by 108
Ultrafast star-shaped acoustic micromixer for high throughput nanoparticle synthesis
Le, N. H. A., Deng, H., Devendran, C., Akhtar, N., Ma, X., Pouton, C. W., Chan, H., Neild, A., & Alan, T. (2019) · Lab on a Chip · doi:10.1039/c9lc01174a · Cited by 100
Lyophilization of Nanocapsules: Instability Sources, Formulation and Process Parameters
Degobert, G., & Aydin, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081112 · Cited by 100
Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes
Babadi, D., Dadashzadeh, S., Osouli, M., Daryabari, M. S., & Haeri, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.041 · Cited by 99
Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
Salehi, B., Prado-Audelo, M. L. D., Cortés, H., Leyva‐Gómez, G., Stojanović-Radić, Z. Z., Singh, Y. D., Patra, J. K., Das, G., Martins, N. A., Martorell, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030746 · Cited by 99
In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design
Cevaal, P. M., Ali, A., Czuba‐Wojnilowicz, E., Symons, J., Lewin, S. R., Cortez‐Jugo, C., & Caruso, F. (2021) · ACS Nano · doi:10.1021/acsnano.0c09514 · Cited by 104
Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery
Parmar, P. K., Wadhawan, J., & Bansal, A. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.010 · Cited by 99
Physically stimulus-responsive nanoparticles for therapy and diagnosis
Farjadian, F., Ghasemi, S., Akbarian, M., Hoseini‐Ghahfarokhi, M., Moghoofei, M., & Doroudian, M. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.952675 · Cited by 105
Modular Acid-Activatable Acetone-Based Ketal-Linked Nanomedicine by Dexamethasone Prodrugs for Enhanced Anti-Rheumatoid Arthritis with Low Side Effects
Xu, Y., Mu, J., Xu, Z., Zhong, H., Chen, Z., Ni, Q., Liang, X., & Guo, S. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05340 · Cited by 99
Machine Learning for Precision Breast Cancer Diagnosis and Prediction of the Nanoparticle Cellular Internalization
Alafeef, M., Srivastava, I., & Pan, D. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00329 · Cited by 101
Targeting Neutrophils for Enhanced Cancer Theranostics
Tang, L., Wang, Z., Mu, Q., Yu, Z., Jacobson, O., Li, L., Yang, W., Huang, C., Kang, F., Fan, W., et al. (2020) · Advanced Materials · doi:10.1002/adma.202002739 · Cited by 98
Approved and marketed nanoparticles for disease targeting and applications in COVID-19
Abdellatif, A. A. H., & Alsowinea, A. F. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0115 · Cited by 105
‘Passive’ nanoparticles for organ-selective systemic delivery: design, mechanism and perspective
Fu, L., Zhang, Y., Farokhzad, R. A., Mendes, B. B., Conde, J., & Shi, J. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00998f · Cited by 100
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis
Ahmadi, M., Ritter, C. A., von Woedtke, T., Bekeschus, S., & Wende, K. (2024) · Chemical Science · doi:10.1039/d3sc05539f · Cited by 106
From design to the clinic: practical guidelines for translating cardiovascular nanomedicine
Cicha, I., Chauvierre, C., Texier, I., Cabella, C., Metselaar, J. M., Szebeni, J., Dézsi, L., Alexiou, C., Rouzet, F., Storm, G., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy219 · Cited by 97
Multivariate analysis for the optimization of microfluidics-assisted nanoprecipitation method intended for the loading of small hydrophilic drugs into PLGA nanoparticles.
Chiesa, E., Dorati, R., Modena, T., Conti, B., & Ida, G. (2018) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2017.11.044 · Cited by 80
Anti-inflammatory Nanomedicine for Cardiovascular Disease
Katsuki, S., Matoba, T., Koga, J., Nakano, K., & Egashira, K. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00087 · Cited by 97
Developments of Smart Drug-Delivery Systems Based on Magnetic Molecularly Imprinted Polymers for Targeted Cancer Therapy: A Short Review
Sanadgol, N., & Wackerlig, J. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090831 · Cited by 98
Advantages and Disadvantages of Using Magnetic Nanoparticles for the Treatment of Complicated Ocular Disorders
Schneider‐Futschik, E. K., & Reyes‐Ortega, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081157 · Cited by 96
Inorganic Nanomaterial‐Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities
Lin, G., Revia, R. A., & Zhang, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007096 · Cited by 97
Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona
Weber, C., Voigt, M., Simon, J., Danner, A., Frey, H., Mailänder, V., Helm, M., Morsbach, S., & Landfester, K. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00539 · Cited by 97
Curcumin as tyrosine kinase inhibitor in cancer treatment
Golonko, A., Lewandowska, H., Świsłocka, R., Jasińska, U., Priebe, W., & Lewandowski, W. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.015 · Cited by 96
Recent Advances in Nanomaterials Development for Nanomedicine and Cancer
Kajani, A. A., Javanmard, S. H., Asadnia, M., & Razmjou, A. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00591 · Cited by 94
Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
He, L., Gu, J. H., Lim, L. Y., Yuan, Z., & Mo, J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00313 · Cited by 94
Implications of nanotechnology for the treatment of cancer: Recent advances
Klochkov, S. G., Неганова, М. Е., Nikolenko, V. N., Chen, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.028 · Cited by 97
Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy
Liu, Q., Duo, Y., Fu, J., Qiu, M., Sun, Z., Adah, D., Kang, J., Xie, Z., Fan, T., Bao, S., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101023 · Cited by 93
Biopolymer based nanoparticles and their therapeutic potential in wound healing – A review
Kumar, M., Mahmood, S., Chopra, S., & Bhatia, A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131335 · Cited by 96
A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research
Mendes, B. B., Zhang, Z., Conniot, J., Sousa, D. P., Ravasco, J. M. J. M., Onweller, L. A., Lorenc, A., Rodrigues, T., Reker, D., & Conde, J. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01673-7 · Cited by 102
Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy
Chen, S., Lai, S. W. T., Brown, C. E., & Feng, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635173 · Cited by 91
“While FDA-approved cancer immunotherapies thus far mainly exploit the adaptive immunity for therapeutic efficacy, there is a growing appreciation for the importance of innate immunity in tumor cell surveillance and eradication.”
BackgroundInfluential
Gold-core silica shell nanoparticles application in imaging and therapy: A review
Moreira, A. F., Rodrigues, C. F., Reis, C. A., Costa, E. C., & Correia, I. J. (2018) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2018.05.022 · Cited by 91
Pulmonary inhalation for disease treatment: Basic research and clinical translations
Wang, B., Wang, L., Yang, Q., Zhang, Y., Qinglai, T., Yang, X., Xiao, Z., Lei, L., & Li, S. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100966 · Cited by 101
Stem cell-extracellular vesicles as drug delivery systems: New frontiers for silk/curcumin nanoparticles
Perteghella, S., Crivelli, B., Catenacci, L., Sorrenti, M., Bruni, G., Necchi, V., Vigani, B., Sorlini, M., Torre, M. L., & Chlapanidas, T. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.005 · Cited by 91
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Shin, H., Park, S. D., Yim, Y., Kim, J., Choi, C., Won, C., & Min, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800065 · Cited by 95
Polyelectrolyte-Based Platforms for the Delivery of Peptides and Proteins
Zhao, L., Skwarczyński, M., & Tóth, I. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01135 · Cited by 90
Functional Nanoparticles for Tumor Penetration of Therapeutics
Su, Y., & Hu, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040193 · Cited by 91
Solution Conditions Tune and Optimize Loading of Therapeutic Polyelectrolytes into Layer-by-Layer Functionalized Liposomes
Correa, S., Boehnke, N., Deiss‐Yehiely, E., & Hammond, P. T. (2019) · ACS Nano · doi:10.1021/acsnano.9b00792 · Cited by 89
Non-invasive Production of Multi-Compartmental Biodegradable Polymer Microneedles for Controlled Intradermal Drug Release of Labile Molecules
Battisti, M., Vecchione, R., Casale, C., Pennacchio, F. A., Lettera, V., Jamaledin, R., Profeta, M., Natale, C. D., Imparato, G., Urciuolo, F., et al. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00296 · Cited by 89
Gold Nanoparticles in Glioma Theranostics
Norouzi, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104753 · Cited by 90
Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation
Taha, M. S., Padmakumar, S., Singh, A., & Amiji, M. M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00744-1 · Cited by 93
Light-triggered switching of liposome surface charge directs delivery of membrane impermeable payloads in vivo
Arias‐Alpizar, G., Kong, L., Vlieg, R. C., Rabe, A., Papadopoulou, P., Meijer, M. S., Bonnet, S., Vogel, S., van Noort, J., Kros, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17360-9 · Cited by 89
Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up
John, R., monpara, J., Swaminathan, S., & Kalhapure, R. S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010131 · Cited by 99
Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages
Ye, J., Yang, Y., Dong, W., Gao, Y., Meng, Y., Wang, H., Li, L., Jin, J., Ji, M., Xia, X., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s207589 · Cited by 87
Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain
Bondarenko, O. M., & Saarma, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.682597 · Cited by 90
Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases
Wu, Y., Vazquez‐Prada, K. X., Liu, Y., Whittaker, A. K., Zhang, R., & Ta, H. T. (2021) · Nanotheranostics · doi:10.7150/ntno.62730 · Cited by 92
Synthesis and Characterization of Zinc Oxide Nanoparticles Using Acacia caesia Bark Extract and Its Photocatalytic and Antimicrobial Activities
Jayachandran, A., Aswathy, T. R., Rahul, A. B., Thara, G. M., & Nair, A. S. (2021) · Catalysts · doi:10.3390/catal11121507 · Cited by 95
Lymph node-targeting nanovaccines for cancer immunotherapy
Wang, Q., Wang, Z., Sun, X., Jiang, Q., Sun, B., He, Z., Zhang, S., Luo, C., & Sun, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.015 · Cited by 90
A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis
Azimizonuzi, H., Ghayourvahdat, A., Ahmed, M. H., Kareem, R. A., Zrzor, A. J., Mansoor, A. S., Athab, Z. H., & Kalavi, S. (2025) · Cancer Cell International · doi:10.1186/s12935-024-03610-z · Cited by 103
Equivalence of complex drug products: advances in and challenges for current regulatory frameworks
Hussaarts, L., Mühlebach, S., Shah, V. P., McNeil, S. E., Borchard, G., Flühmann, B., Weinstein, V., Neervannan, S., Griffiths, E., Jiang, W., et al. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13347 · Cited by 90
Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks
Zhang, Y., Gao, W., Chen, Y., Escajadillo, T., Ungerleider, J. L., Fang, R. H., Christman, K. L., Nizet, V., & Zhang, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b06968 · Cited by 88
Injectable Biomedical Devices for Sensing and Stimulating Internal Body Organs
Jung, Y. H., Kim, J. U., Lee, J. S., Shin, J. H., Jung, W., Ok, J., & Kim, T. (2020) · Advanced Materials · doi:10.1002/adma.201907478 · Cited by 88
Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering
Nabavinia, M., & Beltran‐Huarac, J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00947 · Cited by 87
Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators
Debele, T. A., Yeh, C.-F., & Su, W. (2020) · Cancers · doi:10.3390/cancers12123773 · Cited by 86
Review of Contemporary Self-Assembled Systems for the Controlled Delivery of Therapeutics in Medicine
Osorno, L. L., Brandley, A., Maldonado, D., Yiantsos, A., Mosley, R. J., & Byrne, M. E. (2021) · Nanomaterials · doi:10.3390/nano11020278 · Cited by 91
Challenges towards Targeted Drug Delivery in Cancer Nanomedicines
Hafeez, M. N., Celia, C., & Petrikaitė, V. (2021) · Processes · doi:10.3390/pr9091527 · Cited by 91
Ultrasound-Triggered In Situ Photon Emission for Noninvasive Optogenetics
Wang, W., Wu, X., Tang, K. W. K., Pyatnitskiy, I., Taniguchi, R., Lin, P., Zhou, R., Capocyan, S. L. C., Hong, G., & Wang, H. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c10666 · Cited by 88

Authors: Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R.
Affiliations: The University of Queensland (AU)
Monash University (AU)
Corresponding author: Corrie, Simon R.
ORCID: Bobo, Daniel
Robinson, Kye J.
Thurecht, Kristofer J.
Corrie, Simon R.
Venue: Pharmaceutical Research
Publisher: Springer Science and Business Media LLC
Published: 2016-06-14
Volume: 33
Issue: 10
Pages: 2373-2387
ISSN: 0724-8741 (ISSN-L)
1573-904X
DOI: 10.1007/s11095-016-1958-5
OpenAlex: W2421275313
Cited by: 2,586
References: 94
Citations by year: 2026: 173 · 2025: 202 · 2024: 218 · 2023: 250 · 2022: 302 · 2021: 382 · 2020: 391 · 2019: 323 · 2018: 234 · 2017: 96 · 2016: 12
FWCI: 11.86
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Pharmaceutical Research (publishedVersion)
PubMed (publishedVersion)
Funders: Centre of Excellence in Convergent BioNano Science and Technology (CE140100036)
National Health and Medical Research Council (APP1099231)
Australian Research Council (FT110100284, DP140100951)
Topics: Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Physical Sciences › Materials Science › General Materials Science › Nanotechnology research and applications
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords: nanomedicine, nanoparticle drug delivery, liposomes, polymeric nanoparticles, nanocrystals, micelles, protein nanoparticles, inorganic nanoparticles, metal nanoparticles, theranostics, active targeting, nanomaterial classification, regulatory approval
MeSH terms: Clinical Trials as Topic, Humans, Tissue Distribution, United States, Drug Approval, Nanomedicine, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks